Shreya Vasudeva

2 presentations

• DRUG LIKING AND CRAVING OF INTRAVENOUS KETAMINE WHEN PRESCRIBED FOR THE TREATMENT OF MOOD DISORDERS IN A MONITORED SETTING: A DESCRIPTIVE ANALYSIS

  2026 ASCP Annual Meeting

• T44. EVALUATING THE ABUSE LIABILITY OF KETAMINE IN THE TREATMENT OF MOOD DISORDERS: A SYSTEMATIC REVIEW

  2026 ASCP Annual Meeting